Alcami Corporation Announces Leadership, Appoints Patrick Walsh as Interim CEO

• Bill Humphries resigns as CEO of Alcami Corporation after two years of leadership.

• Patrick Walsh, Board Chair and former CEO, steps in as Interim CEO.

Alcami Corporation, a contract development and manufacturing organisation (CDMO), has announced the resignation of its CEO, Bill Humphries. Effective immediately, Patrick Walsh, the company’s Board Chair and former CEO, will assume the role of Interim CEO.

This leadership change follows a period of significant growth for Alcami, marked by facilities expansion and strategic adjustments to global supply chains. In a statement, Walsh praised Humphries’ contributions during his tenure, noting his advocacy for clients and dedication to the organisation. “On behalf of the Board, I’d like to express gratitude to Bill for his leadership… I am personally grateful for his contributions and wish him all the best in his new opportunity,” Walsh remarked.

Patrick Walsh brings extensive experience to his interim role, having led Alcami as CEO on two prior occasions. Beyond his current role as Board Chair of Alcami, Walsh also serves as Chairman of ANI Pharmaceuticals, MedPharm, and as an Operating Partner at Ampersand Capital Partners.